Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell death beyond apoptosis.

M V Blagosklonny1

  • 1Medicine Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Leukemia
|August 15, 2000
PubMed
Summary
This summary is machine-generated.

Apoptosis, a programmed cell death, is defined by caspase activation. However, slow cell death without caspases also occurs, impacting cancer therapy goals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Koschei the immortal and anti-aging drugs.

Cell death & disease·2014
Same author

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.

Cell death and differentiation·2014
Same author

Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium.

Cell death & disease·2014
Same author

TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.

Cell death & disease·2013
Same author

MEK drives cyclin D1 hyperelevation during geroconversion.

Cell death and differentiation·2013
Same author

Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet.

Cell death & disease·2013
Same journal

Single-cell architecture of purinergic signaling in human cord blood hematopoietic stem and progenitor cells.

Leukemia·2026
Same journal

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same journal

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026
Same journal

PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

Leukemia·2026
Same journal

Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.

Leukemia·2026
Same journal

Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.

Leukemia·2026
See all related articles

Area of Science:

  • Cellular biology
  • Biochemistry
  • Pathology

Background:

  • Apoptosis, or programmed cell death, is traditionally defined morphologically, but this is insufficient for cell culture studies.
  • Tissue necrosis with inflammation is distinct from apoptosis, which is the focus of most cell culture research.
  • A biochemical definition of apoptosis involving caspase activation is emerging, allowing differentiation from other cell death forms.

Purpose of the Study:

  • To differentiate apoptosis from alternative cell death pathways.
  • To investigate the role of caspases in cell death.
  • To re-evaluate cancer therapy goals in light of different cell death mechanisms.

Main Methods:

  • Distinguishing cell death based on caspase activation.

Related Experiment Videos

  • Observing the effects of oncogenic signaling pathways (Ras, Raf, MAPK) on apoptosis.
  • Analyzing the influence of chemotherapeutic drugs on cell death.
  • Correlating cellular susceptibility to spontaneous, starvation-induced, and drug-induced apoptosis.

    • Main Results:

    • Caspase inhibition delays but does not prevent cell death, indicating alternative pathways.
    • Slow cell death without caspase activation can involve DNA fragmentation and is often drug-induced.
    • Oncogenic kinases can inhibit apoptosis, leading to growth arrest and slow cell death.
    • Cellular caspase activity determines susceptibility to apoptosis versus slow cell death.
    • An apoptosis-prone phenotype is characterized by susceptibility to various cell death inducers.

    Conclusions:

    • The biochemical definition of apoptosis (caspase activation) is crucial for distinguishing cell death types.
    • Slow cell death represents a distinct pathway, often influenced by chemotherapeutics and cellular state.
    • Cancer therapy may need to consider cell-selectivity regardless of the death pathway, rather than solely aiming for apoptosis.